Ken Griffin Anika Therapeutics, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,800 shares of ANIK stock, worth $32,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,800
Previous 200
800.0%
Holding current value
$32,148
Previous $4,000
625.0%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ANIK
# of Institutions
113Shares Held
11.3MCall Options Held
200Put Options Held
100-
Trigran Investments, Inc.2.02MShares$36.1 Million4.19% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA765KShares$13.7 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY700KShares$12.5 Million3.96% of portfolio
-
Dimensional Fund Advisors LP Austin, TX657KShares$11.7 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $261M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...